Studies were included if they met the following criteria: (1) enrolled adult patients with acute pancreatitis; (2) measured RDW/Alb ratio at admission; (3) reported outcomes including mortality and/or disease severity; and (4) provided sufficient data to calculate effect estimates. This evidence concerns the gene ALB and acute pancreatitis.